Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
VANCOUVER, BC April 20, 2026 /CNW/ - Labbit, a laboratory information management system (LIMS) built for regulated laboratories running complex workflows, today announced it has retired the Semaphore Solutions brand and consolidated operations under the Labbit name. The move marks the completion of a strategic shift that began over a year ago, when the company shifted from offering professional services across multiple LIMS platforms to dedicating its full services and product teams to Labbit. The company now operates as a single entity focused on laboratory informatics software for molecular diagnostics, cell and gene therapy, manufacturing quality control, and pharma research and development. Labbit was built by the Semaphore Solutions team, which spent more than a decade designing and implementing laboratory systems across regulated laboratory environments. That implementation experience informed the platform's architecture, which uses visual BPMN workflow modeling and a knowl
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Is Veracyte (VCYT) Offering Value After Mixed Returns And Conflicting Valuation Signals [Yahoo! Finance]Yahoo! Finance
- Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026Business Wire
- Veracyte (VCYT) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $45.00 price target on the stock.MarketBeat
- Veracyte (VCYT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $48.00 price target on the stock.MarketBeat
- Veracyte (VCYT) had its price target lowered by Guggenheim from $50.00 to $45.00. They now have a "buy" rating on the stock.MarketBeat
VCYT
Earnings
- 2/25/26 - Beat
VCYT
Sec Filings
- 4/14/26 - Form 4
- 3/27/26 - Form SCHEDULE
- 3/25/26 - Form 3
- VCYT's page on the SEC website